Pfizer Ltd. engages in the business of manufacturing, marketing, trading, import and export of pharmaceutical products. Its product offerings include treatment for depression, erectile dysfunction, high cholesterol, human immunodeficiency virus infection, hypertension, bacterial infections and systemic fungal infections, and other chronic therapeutic which includes pain, respiratory, vitamins or minerals, hospital anti-infectives, neurosciences, and cardiovascular. The firm's products include Prevenar 13, Ativan, Zosyn, Minipress XL, Meronem, Enbrel, Dolonex, Magnex, Trulimax, Neksium, Becosules, Gelusil, Mucaine, Folvite, Autrin, Citralka, and Corex Range. It operates through the India and Outside of India geographical segments. The company was founded on November 21, 1950 and is headquartered in Mumbai, India.
PFIZER LTD financial statements, including revenue, expenses, and profit: The total revenue of PFIZER for the last quarter is 5.92 B INR, and it's 10.02% higher compared to the previous quarter. The net income of Q4 24 is 3.31 B INR.
PFIZER LTD key financial stats and ratios: PFIZER price-to-sales ratio is 10.70. The company has an Enterprise Value to EBITDA ratio of 29.34. As of 2024 they employed 1.77 k people.
PFIZER LTD dividends overview: The last dividend per share was 165.00 INR. As of today, Dividend Yield (TTM)% is 0.66%.
PFIZER LTD earnings per share and revenue: PFIZER earnings per share for the last quarter are 42.00 INR whereas the estimation was 35.85 INR which accounts for 17.15% surprise. Company revenue for the same period amounts to 5.92 B INR despite the estimated figure of 5.83 B INR. Estimated earnings per share for the next quarter are 34.70 INR, and revenue is expected to reach 5.93 B INR. Also watch annual changes over time to get a bigger picture of PFIZER earnings per share and revenue dynamics.
PFIZER LTD revenue breakdown overview: PFIZER LTD revenue for the last year amounted to 22.81 B INR, the most of which — 22.81 B INR — came from its highest performing source at the moment, Pharmaceuticals, the year earlier bringing 21.93 B INR. The greatest contribution to the revenue figure was made by India — last year it brought PFIZER LTD 21.67 B INR, and the year before that — 21.08 B INR.
Comments
Post a Comment